The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic

A growing body of evidence initially suggested that patients with multiple sclerosis (MS) might be more susceptible to coronavirus disease 2019 (COVID-19). Moreover, it was speculated that patients with MS treated with immunosuppressive drugs might be at risk to develop a severe diseases course afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Azimzadeh, Maryam, Möhn, Nora, Ghane Ezabadi, Sajjad, Moghimi Esfandabadi, Zahra, Soleimani, Alireza, Ranjbar, Elaheh, Jahromi, Maliheh, Seyedebrahimi, Reihaneh, Skripuletz, Thomas, Moharrami Kasmaie, Farshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470206/
https://www.ncbi.nlm.nih.gov/pubmed/34572585
http://dx.doi.org/10.3390/biom11091372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470206/
https://www.ncbi.nlm.nih.gov/pubmed/34572585
http://dx.doi.org/10.3390/biom11091372

Ejemplares similares